The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
SOCS-1 and SOCS-3 Block Insulin Signaling by Ubiquitin-mediated Degradation of IRS1 and IRS2
Open accessAbstract
Inflammation associates with peripheral insulin resistance, which dysregulates nutrient homeostasis and leads to diabetes. Inflammation induces the expression of SOCS proteins. We show that SOCS1 or SOCS3 targeted IRS1 and IRS2, two critical signaling molecules for insulin action, for ubiquitin-mediated degradation. SOCS1 or SOCS3 bound both recombinant and endogenous IRS1 and IRS2 and promoted their ubiquitination and subsequent degradation in multiple cell types. Mutations in the conserved SOCS box of SOCS1 abrogated its interaction with the elongin BC ubiquitin-ligase complex without affecting its binding to IRS1 or IRS2. The SOCS1 mutants also failed to promote the ubiquitination and degradation of either IRS1 or IRS2. Adenoviral-mediated expression of SOCS1 in mouse liver dramatically reduced hepatic IRS1 and IRS2 protein levels and caused glucose intolerance; by contrast, expression of the SOCS1 mutants had no effect. Thus, SOCS-mediated degradation of IRS proteins, presumably via the elongin BC ubiquitin-ligase, might be a general mechanism of inflammation-induced insulin resistance, providing a target for therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“obesity-related insulin resistance could result from a diminution in insulin receptor substrate-1 (IRS-1) in animals, secondary to an increase in suppressor of cytokine signaling 3 (SOCS-3), which binds to IRS-1 and leads to its ubiquitylation and proteolysis in experimental animals [5]”
From Bariatric surgery: remission of inflammation, cardiometabolic benefits, and common adverse effects (2020) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,345
Role of Brain Insulin Receptor in Control of Body Weight and Reproduction
Brüning, J. C., Gautam, D., Burks, D. J., Gillette, J., Schubert, M., Orban, P. C., Klein, R., Krone, W., Müller-Wieland, D., & Kahn, C. R. (2000) · Science · doi:10.1126/science.289.5487.2122 · Cited by 2,235
Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M., & Shoelson, S. E. (2001) · Science · doi:10.1126/science.1061620 · Cited by 1,884
Disruption of IRS-2 causes type 2 diabetes in mice
Withers, D. J., Gutierrez, J. S., Towery, H. H., Burks, D. J., Ren, J., Previs, S. F., Zhang, Y., Bernal, D., Pons, S., Shulman, G. I., et al. (1998) · Nature · doi:10.1038/36116 · Cited by 1,775
Insulin resistance and cardiovascular disease
Ginsberg, H. N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10762 · Cited by 1,372
Aguirre, V., Werner, E. D., Giraud, J., Lee, Y. H., Shoelson, S. E., & White, M. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m101521200 · Cited by 1,010
Shimomura, I., Matsuda, M., Hammer, R. E., Bashmakov, Y. K., Brown, M. S., & Goldstein, J. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00010-9 · Cited by 860
SOCS Proteins: Negative Regulators of Cytokine Signaling
Krebs, D. L., & Hilton, D. J. (2001) · Stem Cells · doi:10.1634/stemcells.19-5-378 · Cited by 826
New Perspectives into the Molecular Pathogenesis and Treatment of Type 2 Diabetes
Saltiel, A. R. (2001) · Cell · doi:10.1016/s0092-8674(01)00239-2 · Cited by 688
Zhang, J., Farley, A., Nicholson, S. E., Willson, T. A., Zugaro, L. M., Simpson, R. J., Moritz, R. L., Cary, D., Richardson, R. T., Hausmann, G., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2071 · Cited by 626
Negative Regulation of Cytokine Signaling Pathways
Yasukawa, H., Sasaki, A. T., & Yoshimura, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.143 · Cited by 596
Kamura, T., Sato, S., Haque, D., Liu, L., Kaelin, W. G., Conaway, R. C., & Conaway, J. W. (1998) · Genes & Development · doi:10.1101/gad.12.24.3872 · Cited by 595
Herz, J., & Gerard, R. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.7.2812 · Cited by 514
Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2
Kido, Y., Burks, D. J., Withers, D. J., Brüning, J. C., Kahn, C. R., White, M. F., & Accili, D. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7917 · Cited by 491
SOCS: physiological suppressors of cytokine signaling
Krebs, D. L., & Hilton, D. J. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.16.2813 · Cited by 463
IRS-2 pathways integrate female reproduction and energy homeostasis
Burks, D. J., de Mora, J. F., Schubert, M., Withers, D. J., Myers, M. G., Towery, H. H., Altamuro, S. L., Flint, C. L., & White, M. F. (2000) · Nature · doi:10.1038/35030105 · Cited by 462
Emanuelli, B., Peraldi, P., Filloux, C., Carine Chavey, A., Freidinger, K., Hilton, D. J., Hotamışlıgil, G. S., & OBBERGHEN, E. V. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104602200 · Cited by 449
Mechanisms of TNF-α-induced insulin resistance
Hotamışlıgil, G. S. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1212086 · Cited by 420
Lonergan, K. M., Iliopoulos, O., Ohh, M., Kamura, T., Conaway, R., Conaway, J. W., & Kaelin, W. G. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.2.732 · Cited by 383
The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2
Kamizono, S., Hanada, T., Yasukawa, H., Minoguchi, S., Kato, R., Minoguchi, M., Hattori, K., Hatakeyama, S., Yada, M., Morita, S., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010074200 · Cited by 311
Kerouz, N., Hörsch, D., Pons, S., & Kahn, C. R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119872 · Cited by 296
Rondinone, C. M., Wang, L.-M., Lönnroth, P., Wesslau, C., Pierce, J. H., & Smith, U. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.4171 · Cited by 295
Suppressors of Cytokine Signaling-1 and -6 Associate with and Inhibit the Insulin Receptor
Mooney, R. A., Senn, J. J., Cameron, S. J., Inamdar, N. M., Boivin, L. M., Shang, Y., & Furlanetto, R. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010579200 · Cited by 282
The IRS‐signalling system during insulin and cytokine action
Yenush, L., & White, M. F. (1997) · BioEssays · doi:10.1002/bies.950190608 · Cited by 273
Sun, X., Goldberg, J. L., Qiao, L. Y., & Mitchell, J. J. (1999) · Diabetes · doi:10.2337/diabetes.48.7.1359 · Cited by 218
Rui, L., Fisher, T. L., Thomas, J., & White, M. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105332200 · Cited by 210
Pdx1 restores β cell function in Irs2 knockout mice
Kushner, J. A., Ye, J., Schubert, M., Burks, D. J., Dow, M. A., Flint, C. L., Dutta, S., Wright, C. V. E., Montminy, M., & White, M. F. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14439 · Cited by 188
Naka, T., Tsutsui, H., Fujimoto, M., Kawazoe, Y., Kohzaki, H., Morita, Y., Nakagawa, Narazaki, M., Adachi, K., Yoshimoto, T., et al. (2001) · Immunity · doi:10.1016/s1074-7613(01)00132-7 · Cited by 184
Sakamoto, H., Yasukawa, H., Masuhara, M., Tanimura, S., Sasaki, A. T., Yuge, K., Ohtsubo, M., Ohtsuka, A., Fujita, T., Ohta, T., et al. (1998) · Blood · doi:10.1182/blood.v92.5.1668.417k09_1668_1676 · Cited by 177
Frantsve‐Hawley, J., Schwaller, J., Sternberg, D., Kutok, J. L., & Gilliland, D. G. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.10.3547-3557.2001 · Cited by 171
Suppressor of Cytokine Signaling-1 Inhibits VAV Function through Protein Degradation
Sepulveda, P. D., Ilangumaran, S., & Rottapel, R. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000106200 · Cited by 168
One Ring to Rule a Superfamily of E3 Ubiquitin Ligases
Tyers, M., & Willems, A. R. (1999) · Science · doi:10.1126/science.284.5414.601 · Cited by 165
Kawazoe, Y., Naka, T., Fujimoto, M., Kohzaki, H., Morita, Y., Narazaki, M., Okumura, K., Saitoh, H., Nakagawa, R., Uchiyama, Y., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.263 · Cited by 160
Expression of suppressors of cytokine signaling during liver regeneration
Campbell, J. S., Prichard, L., Schaper, F., Schmitz, J., Stephenson-Famy, A., Rosenfeld, M. E., Argast, G. M., Heinrich, P. C., & Fausto, N. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11867 · Cited by 156
Krebs, D. L., Uren, R. T., Metcalf, D., Rakar, S., Zhang, J., Starr, R., Souza, D. P. D., Hanzinikolas, K., Eyles, J. L., Connolly, L., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.13.4567-4578.2002 · Cited by 150
SOCS Proteins, Regulators of Intracellular Signaling
Chen, X. P., Losman, J. A., & Rothman, P. B. (2000) · Immunity · doi:10.1016/s1074-7613(00)00028-5 · Cited by 145
Waite, K. J., Floyd, Z. E., Arbour-Reily, P., & Stephens, J. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007894200 · Cited by 145
Perspective: The Insulin Signaling System--A Common Link in the Pathogenesis of Type 2 Diabetes
Withers, D. J., & White, M. F. (2000) · Endocrinology · doi:10.1210/endo.141.6.7584 · Cited by 141
Chan, J., Cheung, J., Stehouwer, C. D. A., Emeis, J. J., Tong, P. C. Y., Ko, G., & Yudkin, J. S. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802017 · Cited by 135
Saito, H., Morita, Y., Fujimoto, M., Narazaki, M., Naka, T., & Kishimoto, T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.11.5833 · Cited by 97
Colson, A., Cam, A. L., Maiter, D. M., Edery, M., & Thissen, J. (2000) · Endocrinology · doi:10.1210/endo.141.10.7724 · Cited by 64
THE EFFECT OF BURN INJURY ON SUPPRESSORS OF CYTOKINE SIGNALLING
Ogle, C. K., Kong, F., Guo, X., Wells, D. A., Aosasa, S., Noel, G. J., & Horseman, N. D. (2000) · Shock · doi:10.1097/00024382-200014030-00026 · Cited by 45
Insulin action and type 2 diabetes: lessons from knockout mice
Withers, D. J., & White, M. F. (1999) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-199904000-00010 · Cited by 10
Flagged first, then by citations
1 of the 44 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
Inflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
HEINRICH, P. C., BEHRMANN, I., HAAN, S., HERMANNS, H. M., MÜLLER-NEWEN, G., & SCHAPER, F. (2003) · Biochemical Journal · doi:10.1042/bj20030407 · Cited by 3,272
Adipocytokines: mediators linking adipose tissue, inflammation and immunity
Tilg, H., & Moschen, A. R. (2006) · Nature reviews. Immunology · doi:10.1038/nri1937 · Cited by 3,272
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760
Metadata
- Authors
- Rui, L., Yuan, M., Frantz, D., Shoelson, S., & White, M. F.
- Affiliations
- Joslin Diabetes Center (US)
- Corresponding author
- White, Morris F.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-11
- Volume
- 277
- Issue
- 44
- Pages
- 42394-42398
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2069711307
- Cited by
- 904
- References
- 44
- Citations by year
- 2026: 14 · 2025: 18 · 2024: 18 · 2023: 25 · 2022: 35 · 2021: 39 · 2020: 27 · 2019: 29 · 2018: 42 · 2017: 33 · 2016: 48 · 2015: 27 · 2014: 50 · 2013: 51 · 2012: 57
- FWCI
- 30.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- SOCS1, SOCS3, IRS-1, insulin receptor substrate 2, insulin signaling, ubiquitin-mediated proteolysis, SOCS box, inflammation, insulin resistance, impaired glucose tolerance, liver, diabetes mellitus
- MeSH terms
- Suppressor of Cytokine Signaling 1 Protein, Suppressor of Cytokine Signaling 3 Protein, Elongin, Animals, Carrier Proteins, Glucose, Homeostasis, Humans, Insulin Resistance, Male, Mice, Inbred C57BL, Phosphoproteins, Proteins, Repressor Proteins, Transcription Factors, Ubiquitin, Intracellular Signaling Peptides and Proteins, Suppressor of Cytokine Signaling Proteins, Mice, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review